14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $5.34 $19.02 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
Mar 17, 2017 $23.05 $23.35 $22.25 $22.55 672 611
Mar 16, 2017 $23.60 $23.65 $22.70 $23.40 331 176
Mar 15, 2017 $22.75 $23.80 $22.50 $23.60 325 556
Mar 14, 2017 $23.35 $23.35 $22.55 $22.65 389 312
Mar 13, 2017 $23.95 $24.10 $23.35 $23.65 339 320
Mar 10, 2017 $23.95 $24.25 $23.00 $23.95 477 429
Mar 09, 2017 $22.45 $24.05 $22.45 $23.60 652 675
Mar 08, 2017 $21.70 $22.95 $21.50 $22.40 384 543
Mar 07, 2017 $22.25 $22.70 $21.70 $21.70 393 799
Mar 06, 2017 $23.45 $23.45 $22.15 $22.70 414 846
Mar 03, 2017 $23.30 $23.95 $23.05 $23.60 355 815
Mar 02, 2017 $23.80 $24.65 $23.35 $23.40 1 087 896
Mar 01, 2017 $23.15 $24.08 $22.80 $23.90 865 189
Feb 28, 2017 $23.45 $23.58 $22.80 $22.85 599 620
Feb 27, 2017 $21.90 $23.58 $21.90 $23.50 721 784
Feb 24, 2017 $20.00 $21.80 $19.05 $21.78 1 053 563
Feb 23, 2017 $21.80 $21.90 $20.85 $21.90 576 720
Feb 22, 2017 $22.55 $22.80 $21.65 $21.75 531 562
Feb 21, 2017 $23.55 $23.75 $22.40 $22.45 626 698
Feb 17, 2017 $23.35 $23.50 $22.25 $23.30 611 491
Feb 16, 2017 $24.45 $24.50 $23.20 $23.40 594 838
Feb 15, 2017 $23.95 $24.50 $23.50 $24.40 477 482
Feb 14, 2017 $23.80 $24.10 $23.10 $24.05 474 802
Feb 13, 2017 $24.95 $25.20 $23.85 $24.00 491 372
Feb 10, 2017 $24.95 $25.45 $24.30 $24.80 741 292
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT